Dispersive Completes HIPAA Compliance Examination to Strengthen Stealth Networking Protections for Healthcare and Life Sciences

ATLANTA--(BUSINESS WIRE)--Dispersive Holdings, Inc. (Dispersive®), an innovator in stealth networking and post-quantum resilient communications, today announced the successful completion of an independent HIPAA compliance examination conducted by Johanson Group LLP. The examination evaluated Dispersive’s virtual networking platform against the requirements defined in the HIPAA Audit Program.

The assessment affirmed that Dispersive has identified the risks associated with HIPAA compliance and has implemented a control framework designed to safeguard electronic protected health information (ePHI) in accordance with the HIPAA Audit Program.

This milestone reinforces Dispersive’s commitment to protecting sensitive clinical, operational, research, and patient data across distributed networks. In particular, healthcare providers, telemedicine platforms, pharmaceutical companies, clinical research organizations (CROs), and critical infrastructure environments.

“Healthcare organizations cannot afford an attack surface,” said Rajiv Pimplaskar, CEO of Dispersive. “The stakes are too high. Our stealth networking architecture ensures that users, devices and the network edge are invisible and sensitive data flows are resilient and encrypted. Completing this HIPAA examination further validates our ability to help healthcare and life sciences organizations securely connect staff, systems, and cloud environments without expanding the attack surface.”

Dispersive’s stealth networking platform obfuscates and splits traffic across multiple dynamic network paths, making communications extremely difficult to detect, intercept, or disrupt. The result is an overlay network that provides zero-trust access, multi-path resilience, and quantum-resistant encryption that does not require organizations to rip and replace their existing infrastructure.

Healthcare organizations are increasingly prioritizing architectures that:

• Isolate sensitive systems and clinical workloads
• Protect remote care delivery and hybrid workforce access
• Reduce ransomware and OT/IoT exposure
• Support secure multi-cloud and AI-assisted workflows
• Ensure continuity during outages and degradation events

Dispersive’s HIPAA examination underscores the company’s continued investment in compliance, secure-by-design networking, and trust for regulated industries.

About Dispersive

Dispersive Holdings, Inc. (Dispersive®) is a global innovator in stealth networking. Born from DARPA research and backed by 53 issued patents, Dispersive’s multipath software dynamically splits and obscures traffic across changing channels, making networks virtually invisible while ensuring resilience and quantum readiness. Trusted by defense, intelligence, and high-security enterprises, Dispersive is redefining how the world connects securely. Learn more at www.dispersive.io.